No Data
Bluebird Bio Price Target Lowered to $8 at RBC Capital on 'Limited Cash Runway'
RBC Adjusts Price Target on Bluebird Bio to $8 From $80 Amid Reverse Stock Split, 'Limited Cash Runway,' Keeps Sector Perform, Speculative Risk
Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Bluebird Bio (BLUE)
Express News | Bluebird bio Inc : Leerink Partners Raises Target Price to $10 From $1
Bluebird Bio Is Maintained at Overweight by Barclays
Bluebird Bio Analyst Ratings
玄学炒股的美股韭菜 : Already all-in.